Intelligence Platform

Patents

Browse 2,152 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 6090795

Human derived monocyte attracting purified peptide products useful in a method of treating

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6087110

Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encod

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6084090

Human papilloma virus anti-sense oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6084069

Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6084063

Signal transduction inhibitors of allergic reactions

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6083703

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6083503

Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases,

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6083502

Mesothelium antigen and methods and kits for targeting it

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6077935

Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing fo

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 20 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6074864

Cloned DNA for synthesizing unique glucocerebrosidase

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 13 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6074644

Nucleic acids encoding immunotoxins containing a disulfide-stabilized antibody fragment re

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 13 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6072031

Cellular apoptosis susceptibility protein (CSP)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6071949

Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6071709

Nerve growth factor/receptor complex

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6068844

Increased resistance to stroke by developing immunologic tolerance to myelin or components

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6066656

2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonami

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6066642

Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their p

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6063905

Recombinant human IGA-J. chain dimer

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6060505

Method of treating cancer using C-26 modified bryostatin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6060458

Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6060310

Transcription factor decoy and tumor growth inhibitor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6057346

Inhibition of retroviral LTR promoters by calcium response modifiers

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6057298

Keratin K1 expression vectors and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6056952

Selective elimination of T cells that recognize specific preselected targets

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)